Abstract
Hypothalamic corticotropin-releasing hormone (CRH)-containing neurons represent the integrative center of the hypothalamo-pituitary-adrenal (HPA) axis. Activation of that axis during the stress response is partly modulated in function of the metabolic status of the individual. In contrast, glucocorticoid hormones play an important permissive role upon feeding and central metabolic regulations. Thus, a dynamic interplay seems to exist between the activity of the HPA axis and the regulation of energy homeostasis. The adipose tissue, by way of leptin secretion, is an important partner in this crosstalk: glucocorticoids and possibly ACTH have been shown to stimulate leptin biosynthesis and secretion, and in turn, leptin probably exerts a down-regulation upon adrenal gland activity. This review presents the current evidence, obtained both in animal models and in the human, demonstrating the physiological importance of this crosstalk for the adaptation of the individual to external aggressions, i.e. for the stress response.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432
Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM 1995 Weight-reducing effects of the plasma protein encoded by theobesegene. Science 269:543–546
Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F 1995 Effects of theobesegene product on body weight regulation inob/obmice. Science 269:540–543
Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P 1995 Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural network. Science 269:546–549
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292–295
Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O’Rahilly S 1997 Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903–908
Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B 1998 A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398–401
Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD 1998 A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 18:213–215
Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D, Jr., Woods SC, Seeley RJ, Weigle DS 1996 Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45:531–535
Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, MacKellar W, Rosteck PR, Jr., Schoner B, Smith D, Tinsley FC, Zhang X-Y, Heiman M 1995 The role of neuropeptide Y in the antiobesity action of theobesegene product. Nature 377:530–532
Bergonzelli GE, Pralong FP, Glauser M, Cavadas C, Grouzmann E, Gaillard RC 2001 Interplay Between Galanin and Leptin in the Hypothalamic Control of Feeding via Corticotropin-Releasing Hormone and Neuropeptide Y. Diabetes 50:2666–2672.
Clark JT, Kalra PS, Crowley WR, Kalra SP 1984 Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115:427–429
Levine AS, Morley JE 1984 Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides 5:1025–1029
Gruaz NM, Pierroz DD, Rohner-Jeanrenaud F, Sizonenko PC, Aubert ML 1993 Evidence that neuropeptide Y could represent a neuroendocrine inhibitor of sexual maturation in unfavorable metabolic conditions in the rat. Endocrinology 133:1891–1894
Kalra SP, Crowley WR 1984 Norepinephrine-like effects of neuropeptide Y in the rat. Life Sci 35:1173–1176
McDonald JK, Lumpkin MD, Samson WK, McCann SM 1985 Neuropeptide Y affects secretion of luteinizing hormone and growth hormone in ovariectomized rats. Proc Natl Acad Sci USA 82:561–564
Wahlestedt C, Skagerberg G, Ekman R, Heilig M, Sundler F, Hakanson R 1987 Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res 417:33–38
Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI 1995 Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263–1271
Walter MR 1997 Structural biology of cytokines, their receptors, and signaling complexes: implications for the immune and neuroendocrine circuit. Chem Immunol 69:76–98
Ghilardi N, Skoda RC 1997 The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol Endocrinol 11:393–399
Touw IP, De Koning JP, Ward AC, Hermans MH 2000 Signaling mechanisms of cytokine receptors and their perturbances in disease. Mol Cell Endocrinol 160:1–9
Szanto I, Kahn CR 2000 Selective interaction between leptin and insulin signaling pathways in a hepatic cell line. Proc Natl Acad Sci U S A 97:2355–2360
Yamashita T, Murakami T, Otani S, Kuwajima M, Shima K 1998 Leptin receptor signal transduction: OBRa and OBRb of fa type. Biochem Biophys Res Commun 246:752–759
Hoggard N, Mercer JG, Rayner DV, Moar K, Trayhurn P, Williams LN 1997 Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RTPCR andin situhybridization. Biochem Biophys Res Commun 232:383–387
Guan XM, Hess JF, Yu H, Hey PJ, van der Ploeg LH 1997 Differential expression of mRNA for leptin receptor isoforms in the rat brain. Mol Cell Endocrinol 133:1–7
Cioffi JA, Van Blerkom J, Antczak M, Schafer A, Wittmer S, Snodgrass HR 1997 The expression of leptin and its receptors in pre-ovulatory human follicles. Mol Hum Reprod 3:467–472
Pralong FP, Roduit R, Waeber G, Castillo E, Mosimann F, Thorens B, Gaillard RC 1998 Leptin inhibits directly glucocorticoid secretion by normal human and rat adrenal gland. Endocrinology 139:4264–4268
Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS 1996 Role of leptin in the neuroendocrine response to fasting. Nature 382:250–252
Garthwaite TL, Martinson DR, Tseng LF, Hagen TC, Menahan LA 1980 A longitudinal hormonal profile of the genetically obese mouse. Endocrinology 107:671–676
Edwardson JA, Hough CAM 1975 The pituitary-adrenal system of the genetically obese(ob/ob)mouse. J Endocrinol 65:99–107
Spinedi E, Gaillard RC 1998 A regulatory loop between the hypothalamo-pituitaryadrenal (HPA) axis and circulating leptin: a physiological role of ACTH. Endocrinology 139:4016–4020
Slieker LJ, Sloop KW, Surface PL, Kriauciunas A, LaQuier F, Manetta J, BueValleskey J, Stephens TW 1996 Regulation of expression of ObmRNA and protein by glucocorticoids and cAMP. J Biol Chem 271:5301–5304
De Vos P, Saladin R, Auwerx J, Staels B 1995 Induction of Obgene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 270:15958–15961
Chautard T, Spinedi E, Voirol M, Pralong FP, Gaillard RC 1999 Role of glucocorticoids in the response of the hypothalamo-corticotrope, immune and adipose systems to repeated endotoxin administration. Neuroendocrinology 69:360–369
Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS 1997 Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 138:3859–3863
Giovambattista A, Chisari AN, Gaillard RC, Spinedi E 2000 Food intake-induced leptin secretion modulates hypothalamo-pituitary-adrenal axis response and hypothalamic Ob-Rb expression to insulin administration. Neuroendocrinology 72:341–349.
Morimoto I, Yamamoto S, Kai K, Fujihira T, Morita E, Eto S 2000 Centrally administered murine-leptin stimulates the hypothalamus-pituitary-adrenal axis through arginine-vasopressin. Neuroendocrinology 71:366–374.
Costa A, Poma A, Martignoni E, Nappi G, Ur E, Grossman A 1997 Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants. Neuroreport 8:1131–1134.
Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR, Grunfeld C 1999 Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 276:R136–142
Faggioni R, Moser A, Feingold KR, Grunfeld C 2000 Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am J Pathol 156:1781–1787
Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrao AB, Gold P, Chrousos GP 1998 Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab 83:280–283
Torpy DJ, Bornstein SR, Chrousos GP 1998 Leptin and interleukin-6 in sepsis. Horm Metab Res 30:726–729
Licino J, Mantzoros C, Negrao AB, Cizza G, Wong ML, Bongiorno PB, Chrousos GP, Karp B, Allen C, Flier JS, Gold PW 1997 Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nature Med 3:575–579
Glasow A, Haidan A, Hilbers U, Breidert M, Gillespie J, Scherbaum WA, Chrousos GP, Bornstein SR 1998 Expression of Ob receptor in normal human adrenals: differential regulation of adrenocortical and adrenomedullary function by leptin. J Clin Endocrinol Metab 83:4459–4466.
Bornstein RS, Uhlmann K, Haidan A, Ehrhart-Bornstein M, Scherbaum WA 1997 Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland. Leptin inhibits cortisol release directly. Diabetes 46:1235–1238
Kruse M, Bornstein SR, Uhlmann K, Paeth G, Scherbaum WA 1998 Leptin down-regulates the steroid producing system in the adrenal. Endocr Res 24:587–590
Dallman MF, Strack AM, Akana SF, Bradbury MJ, Hanson ES, Smith M 1993 Feast and famine: critical role of glucocorticoids wtih insulin in daily energy flow. Front Neuroendocrinol 14:303–347
Freedman MR, Horwitz BA, Stern JS 1986 Effect of adrenalectomy and glucocorticoid replacement on development of obesity. American Journal of Physiology 250:R595–R607
Stocco DM, Clark BJ 1996 Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 17:221–244
Cherradi N, Capponi AM, Gaillard RC, Pralong FP 2001 Decreased expression of steroidogenic acute regulatory protein: a novel mechanism participating in the leptininduced inhibition of glucocorticoid biosynthesis. Endocrinology 142:3302–3308.
Kiriakidou M, McAllister JM, Sugawara T, Strauss JF, 3rd 1996 Expression of steroidogenic acute regulatory protein (StAR) in the human ovary. J Clin Endocrinol Metab 81:4122–4128.
Zachow RJ, Magoffin DA 1997 Direct intraovarian effects of leptin: impairment of the synergistic action of insulin-like growth factor-I on follicle-stimulating hormone-dependent estradio1–17 beta production by rat ovarian granulosa cells. Endocrinology 138:847–850
Pralong FP, Gomez F, Guillou L, Mosimann F, Franscella S, Gaillard RC 1999 Food-dependent Cushing’s syndrome: possible involvement of leptin in cortisol hypersecretion. J Clin Endocrinol Metab 84:3817–3822
Cohen P, Zhao C, Cai X, Montez JM, Rohani SC, Feinstein P, Mombaerts P, Friedman JM 2001 Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest 108:1113–1121.
Baskin DG, Breininger JF, Schwartz MW 1999 Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes 48:828–833.
Allen YS, Adrian TE, Allen JM, Tatemoto K, Crow TJ, Bloom SR, Polak JM 1983 Neuropeptide Y distribution in the rat brain. Science 221:877–879
Edwards CM, Abusnana S, Sunter D, Murphy KG, Ghatei MA, Bloom SR 1999 The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol 160:R7–12.
Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D, Jr., Woods SC, Seeley RJ, Weigle DS 1996 Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45:531–535
Vidal S, Cohen SM, Horvath E, Kovacs K, Scheithauer BW, Burguera BG, Lloyd RV 2000 Subcellular localization of leptin in non-tumorous and adenomatous human pituitaries: an immuno-ultrastructural study. J Histochem Cytochem 48:1147–1152.
Iqbal J, Pompolo S, Considine RV, Clarke IJ 2000 Localization of leptin receptor-like immunoreactivity in the corticotropes, somatotropes, and gonadotropes in the ovine anterior pituitary. Endocrinology 141:1515–1520.
Dieterich KD, Lehnert H 1998 Expression of leptin receptor mRNA and the long form splice variant in human anterior pituitary and pituitary adenoma. Exp Clin Endocrinol Diabetes 106:522–525.
Pralong FP, Gaillard RC 2001 Neuroendocrine effects of leptin. Pituitary 4:25–32
Renz M, Tomlinson E, Hultgren B, Levin N, Gu Q, Shimkets RA, Lewin DA, Stewart TA 2000 Quantitative expression analysis of genes regulated by both obesity and leptin reveals a regulatory loop between leptin and pituitary-derived ACTH. J Biol Chem 275:10429–10436.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pralong, F.P., Gaillard, R.C. (2003). Leptin and the Hypothalamopituitary-Adrenal Axis. In: Gaillard, R.C. (eds) The Acth Axis: Pathogenesis, Diagnosis and Treatment. Endocrine Updates, vol 21. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0501-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0501-3_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5108-5
Online ISBN: 978-1-4615-0501-3
eBook Packages: Springer Book Archive